Search
Illinois Paid Clinical Trials
A listing of 2738 clinical trials in Illinois actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
2725 - 2736 of 2738
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Conditions:
Healthy
Healthy Volunteer Study
Featured Trial
Herpes Clinical Trial
Recruiting
Help move the future of herpes simplex virus type 2 (HSV-2) genital herpes forward by participating in the Vantage Trial for an investigational vaccine.
Conditions:
HSV-2 Infection
HSV-2
Herpes
Herpes Simplex
Genital Herpes
Genital Herpes Simplex Type 2
HSV-2 Genital Herpes
HIV-1 and HSV-2 Coinfection
Featured Trial
Fronto-Temporal Dementia Research Study
Recruiting
The aim of this study is to better understand the genetics of FTD, in order to
empower researchers with the data they need to potentially identify treatment
options. Help researchers accelerate their understanding of Frontotemporal
Dementia and get access to free, at-home genetic testing and genetic counseling
before and after your test.
empower researchers with the data they need to potentially identify treatment
options. Help researchers accelerate their understanding of Frontotemporal
Dementia and get access to free, at-home genetic testing and genetic counseling
before and after your test.
Conditions:
Dementia
Frontotemporal Dementia
Alzheimer Dementia
Dementia Alzheimers
Mild Dementia
Dementia
Alzheimer Type
Alzheimer Disease
Alzheimer's Disease
Dementia of Alzheimer Type
Parkinson's Disease
Parkinson Disease
Idiopathic Parkinson's Disease
ALS
Memory Disorders
Memory Impairment
Memory Loss
Age-Related Memory Disorders
Featured Trial
Clinical Research for Alpha-1 Antitrypsin Deficiency–Associated Liver Disease
Recruiting
The Redwood Study is currently enrolling adults 18 to 75 years of age with Alpha-1
Liver Disease. The purpose of the study is to evaluate how safe and effective an
investigational study drug is compared to a placebo (both groups will receive
injections, but the placebo contains no active medication) in the treatment of liver
disease. If you or any of your family members have a confirmed or suspected
diagnosis of Alpha-1 Liver Disease, you may be eligible.
Liver Disease. The purpose of the study is to evaluate how safe and effective an
investigational study drug is compared to a placebo (both groups will receive
injections, but the placebo contains no active medication) in the treatment of liver
disease. If you or any of your family members have a confirmed or suspected
diagnosis of Alpha-1 Liver Disease, you may be eligible.
Conditions:
Crohn's Disease
COPD
Chronic Obstructive Pulmonary Disease (COPD)
Emphysema or COPD
Alpha 1-Antitrypsin Deficiency
AAT Deficiency
AATD
Chronic Obstructive Pulmonary Disease
Emphysema
Pulmonary Emphysema
Bronchiectasis
Panniculitis
Hepatocellular Carcinoma
Cirrhosis
Liver Cirrhosis
Cirrhosis
Liver
Cystic Fibrosis
Idiopathic Pulmonary Fibrosis
Pulmonary Fibrosis
Non-Alcoholic Fatty Liver Disease
Liver Diseases
Liver Disease
ATI Evidence-based Guide Investigating Clinical Services
Recruiting
The investigators goal is to provide a mechanism that allows for a better understanding of patient outcomes following rehabilitation. This includes functional outcomes measured by standardized and validated tools from the published literature. It incorporates comorbidities and patient demographic characteristics. It includes measures of general health as well along with activities of daily living and behavioral health aspects. Measures of quality and satisfaction and use of Net Promoter Scores a... Read More
Gender:
All
Ages:
16 years and above
Trial Updated:
07/01/2019
Locations: ATI, Bolingbrook, Illinois
Conditions: Spine Osteoarthritis, Shoulder Impingement Syndrome, Knee Osteoarthritis, Hip Osteoarthritis, Osteoarthritis, Carpal Tunnel Syndrome, Fracture, Sprain
Fentanyl Effect on Blood Pressure in Elderly Patients After Induction of General Anesthesia
Recruiting
Hypotension is frequently encountered after induction of general anesthesia. It can be pronounced in elderly patients and can require administration of vasopressor agents including ephedrine and phenylephrine. Intraoperative hypotension, especially prolonged episodes, can contribute to an increase in morbidity and mortality in the postoperative period as suggested by some former studies. The investigators hypothesize that fentanyl can contribute to the decrease in blood pressure (BP) that is see... Read More
Gender:
All
Ages:
60 years and above
Trial Updated:
06/04/2019
Locations: Loyola University Medical Center, Maywood, Illinois
Conditions: Hypotension
Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy
Recruiting
The purpose of this study is to evaluate the safety and efficacy of OMS721 in patients with IgA nephropathy. The study will assess proteinuria by 24-hour urine protein excretion (UPE) in g/day at 36 weeks from beginning of treatment.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/28/2019
Locations: Omeros Investigational Site, Crystal Lake, Illinois
Conditions: IgA Nephropathy
Osteopathic Manipulation in Breastfed Newborns
Recruiting
Osteopathic manipulative treatment(OMT) is a form of manual medicine in which a trained physician uses his or her hands to diagnose areas of restriction in a patient's body. The physician then uses his or her hands to manually correct the restriction, to improve body function. The research team will be performing OMT on breastfed newborns that have been identified by lactation consultants as having a feeding issues. The team will then compare the feeding behaviors of these babies to those in the... Read More
Gender:
All
Ages:
2 weeks and below
Trial Updated:
05/08/2019
Locations: UnityPoint Methodist Peoria Medical Center, Peoria, Illinois
Conditions: Osteopathic Medicine, Breast Feeding
Effect of Stimulant Drugs on Social Perception
Recruiting
The study will improve our understanding of the "prosocial" effects of ± 3,4-Methylenedioxymethamphetamine (MDMA), relative to a prototypical stimulant, methamphetamine (MA). The investigators seek to characterize the "uniquely social" effects of MDMA.
Gender:
All
Ages:
Between 18 years and 35 years
Trial Updated:
12/28/2018
Locations: University of Chicago, Chicago, Illinois
Conditions: Effects of MDMA on Healthy Human Volunteers
Mood Effects of Serotonin Agonists
Recruiting
The purpose of this study is to determine the effects of very low doses of serotonergic agonists on depressed mood in human volunteers.
Gender:
All
Ages:
Between 18 years and 35 years
Trial Updated:
12/28/2018
Locations: Matthew Bona, Chicago, Illinois
Conditions: Healthy
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Recruiting
This is an observational, multicenter study to determine the prevalence of Cerebrotendinous Xanthomatosis (CTX) in patient populations diagnosed with early-onset idiopathic bilateral cataracts. Patients who are potentially eligible for study participation will be identified through a chart review of patients who were seen at each study site prior to that site's initiation, or by entering care at the site while the site is participating in the trial.
Gender:
All
Ages:
Between 2 years and 21 years
Trial Updated:
11/07/2018
Locations: Lurie Children's Hospital of Chicago, Chicago, Illinois
Conditions: Cerebrotendinous Xanthomatosis (CTX)
Diet Quality and Cognitive Control Function in Early Childhood: A Pilot Study
Recruiting
This study aims to study the relationship between diet and cognitive function among 4-5-year-olds.
Gender:
All
Ages:
Between 4 years and 5 years
Trial Updated:
10/09/2018
Locations: Department of Kinesiology and Community Health, Urbana, Illinois
Conditions: Diet Habit, Cognitive Function
Peer MI for Substance-using Emerging Adults
Recruiting
The main purpose of this project is to test whether Peer-Enhanced Motivational Interviewing (PMI) results in superior alcohol and marijuana use outcomes for emerging adults (EAs, ages 18-29) and their peers. Ninety peer dyads (total n = 180, ntarget client = 90, npeer = 90) are randomized to receive either Peer-Enhanced Motivational Interviewing (PMI) or Waitlist Control (WC).
Gender:
All
Ages:
Between 18 years and 29 years
Trial Updated:
10/09/2018
Locations: School of Social Work, Urbana, Illinois
Conditions: Substance-Related Disorders
TARGET Intracranial Aneurysm Coiling Registry
Recruiting
The purpose of this prospective registry is to collect real world, post-marketing data on the use of Stryker Target® 360,Target® 2D, and 2nd generation Target® Nano coils for the embolization of ruptured or unruptured intracranial saccular aneurysms. Up to 300 patients (150 in the TARGET 360°/Helical arm and 150 in the New NANO arm) presenting with intracranial aneurysms suitable for coil embolization will be enrolled at up to 20 sites. A post hoc analysis comparing Target® 360° and Target® 2D c... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
07/20/2018
Locations: Presence Saint Joseph Medical Center, Joliet, Illinois
Conditions: Intracranial Aneurysms
The Genetic Basis for Atrial Fibrillation
Recruiting
Atrial fibrillation (AF) is reaching epidemic proportions in the aging U.S. and European populations, but the mechanisms of increased susceptibility to atrial fibrillation are still unknown. In this study, we look to further examine genetic and medical co-morbidity influence of atrial fibrillation duration and response to medications. In Specific Aim 1, we propose the creation of a Veterans Affairs AF Biorepository (VAAFBio), which is a resource that will collect and store clinical, demographic,... Read More
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
06/08/2018
Locations: Jesse Brown VA Medical Center, Chicago, Illinois
Conditions: Atrial Fibrillation
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Recruiting
Phase I clinical trial to determine the Phase II dose of autologous TIL 1383I TCR gene modified T Cells using a retrovirus. This is a novel National Cancer Institute (NCI) funded investigator initiated therapy for patients with advanced melanoma.
Gender:
All
Ages:
Between 18 years and 89 years
Trial Updated:
03/08/2018
Locations: Loyola University Medical Center, Maywood, Illinois
Conditions: Melanoma